Global Ovarian Cancer Diagnostic Market

Ovarian Cancer Diagnostic Market Size, Share, Growth Analysis, By Type(Epithelial tumours, germ cell tumours, stromal tumours), By End user(Hospital Laboratories, diagnostic centres, Research Institutes, others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35F2014 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 64 |Figures: 75

Ovarian Cancer Diagnostic Market Insights

Global Ovarian Cancer Diagnostic Market size was valued at USD 1.57 billion in 2019 and is poised to grow from USD 1.77 billion in 2023 to USD 9.67 billion by 2031, growing at a CAGR of 23.7% in the forecast period (2024-2031).

Ovarian cancer is a type of cancer that occurs in the ovaries; there are several types of ovarian cancer, the most common of which is epithelial ovarian cancer. The primary cause of this type of cancer is uncontrollable cell growth in the ovarian tissue, and it is one of the leading causes of death in women worldwide. It is the fifth most common cause of cancer death in women worldwide, and the tenth most common cause of cancer death in women in the United States. Novel approaches in ovarian cancer treatment is the major factor escalating the market expansion, also increased funding for cancer research, rising in health awareness and increase in aged women population all over the world are the most common factors among others that driving the ovarian cancer diagnostics market. The development and technical advancements in the machines that are used for the treatment can create new opportunities for ovarian cancer diagnostics market in the forecasted period.

Government and research department are focusing on advanced cancer diagnostic methods that could detect the cancer at its early level as the cancer diagnostic methods of present detect the cancer when it has already spread at an advanced level. Rising awareness, increasing focus of government, researchers and other medical organizations to provide convenient and in-time diagnosis of ovarian cancer method are key factors for boosting the market growth.

To get more reports on the above market click here to Buy The Report

Ovarian Cancer Diagnostic Market Segmental Analysis

Global ovarian cancer diagnostic market has segmented on the basis of type, end user, and region. On the basis of type, it has been classified epithelial tumours, germ cell tumours, and stromal tumours. On the basis of end user, it has been classified as hospitals laboratories, diagnostic centres, research institutes and others. On the basis of region, it is classified as North America, Europe, Asia-Pacific Latin America, and Middle East & Africa.

Ovarian Cancer Diagnostic Market Analysis by Type

Based on type, the epithelial tumour segment dominated the ovarian cancer diagnostic market. Epithelial ovarian cancer starts in the epithelial layer that protects the ovary. The majority of patients with epithelial cell carcinoma are diagnosed after the tumour has spread to the peritoneal cavity. Seventy to eighty percent of patients are diagnosed at an advanced stage, limiting treatment options and survival rates significantly. The epithelial tumour account for majority of instances, thus the demand for epithelial tumour diagnostics is substantially more than the demand for germ cell carcinoma and stromal carcinoma tumour diagnostics. Stromal tumours form in the tissues that produce hormones such as estrogen, progesterone, and testosterone. Although rare, germ cell tumours are most common in women between the ages of 20 and 30.

Ovarian Cancer Diagnostic Market Analysis by End User

Based on end user, demand for ovarian cancer diagnostics in hospital associated labs is expected to be most eminent and it is predicted that it will enhance as the instances of ovarian cancer rise. It is due to increasing patient inflow for cancer diagnosis in hospitals, rising consumer awareness, and rising investments in healthcare infrastructure in developing and underdeveloped countries are all contributing to the growth of the segment. Thus, the hospital laboratories segment is anticipated for largest revenue share among end user segments in the global market in the coming year. Moreover, the research institutes segment is expected to grow at the fastest rate during the forecast period because of increased funding for cancer research worldwide.

To get detailed analysis on other segments, Request For Free Sample Report

Ovarian Cancer Diagnostic Market Regional Insights

North America accounted for more market value growth this is because of strong commercial performances of gynecologic diagnostics in the United States. Other factors contributing to the growth of the market in this region include favourable government initiatives, increase in healthcare expenditure, and presence of key manufacturers.

Moreover, Asia Pacific is expected to grow at the fastest rate during the forecast period due to factors such as overall economic development, improvements in healthcare infrastructure, increase in disposable income, and rise in consumer awareness. The ovarian cancer diagnostics market in developing countries like China, India, and South Korea is expected to grow rapidly during the forecast period.

The MEA region is expected to see relatively slower adoption of ovarian cancer diagnostics because of the slow adoption of new diagnostic methods and limited healthcare spending potential.

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Ovarian Cancer Diagnostic Market Dynamics

Ovarian Cancer Diagnostic Market Driver

  • Increase in the number of elderly women is driving the ovarian cancer diagnostics market. The growing elderly female population leads to the increase in the chances of infected ovarian cancer. This increase in population has the potential to drive the ovarian cancer diagnostics market. As a result, governments launch initiatives to expand health care and treatment.
  • Rising healthcare awareness is driving the market growth. As people become more aware of their health, drugs like Bevacizumab (Avastin) and Pazopanib (Votrient) are expected to boost the market. The advancements in ovarian cancer medications are expected to benefit the drug market at the same time. Various studies are being conducted on treatments for the ovarian cancer, and some of those that are currently being conducted may soon be available in the market.
  • Patent expiration boosting the new entries in market. The expiration of old companies' patents can be advantageous to new companies entering the market. Adoption of new combination therapies for treatment is a major driver for the ovarian cancer diagnostic market. Government and private funding for research and development is an added bonus for the market.

Ovarian Cancer Diagnostic Market Restraint

  • Ignorance of ovarian cancer symptoms may halt the market. Ovarian cancer symptoms are frequently ignored or misdiagnosed. These symptoms are also confused with those of other health issues, resulting in late detection and correct diagnosis of the disease. The severity of ovarian cancer may be increased by late detection and treatment.

Request Free Customization of this report to help us to meet your business objectives.

Ovarian Cancer Diagnostic Market Competitive Landscape

Global ovarian cancer diagnostics market is highly competitive and fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, acquisitions, co-development deals, product launches & development, collaborations and partnerships are adopted by these players to thrive in the competitive market. The most recent advancements in ovarian cancer diagnostics are desperately needed in the industry to detect cancer in its early stages and treat it without causing significant damage to the affected person's internal organs. Top ovarian cancer diagnosis instrument manufacturers are investing in research and development of devices and instruments that will aid in the diagnosis and treatment of ovarian cancer more effectively and efficiently.

Top Players in the Ovarian Cancer Diagnostics Market

  • Abbott Laboratories
  • Roche
  • Quest Diagnostics
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Becton, Dickinson and Company (BD)
  • bioMérieux SA
  • Hologic, Inc.
  • Illumina, Inc.
  • Myriad Genetics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Genomic Health, Inc.
  • Agilent Technologies
  • AstraZeneca
  • Bio-Rad Laboratories, Inc.
  • GE Healthcare
  • Merck KGaA
  • NanoString Technologies
  • Oncocyte Corporation
  • PerkinElmer Inc.

Ovarian Cancer Diagnostic Market Recent Developments

  • On 12 May 2022, Roche established partnership with the Global Fund to support low- and middle-income countries in strengthening critical diagnostics infrastructure.
  • On 09 September 2021, Boehringer Ingelheim acquired Abexxa Biologics to further grow its research efforts in cancer immunology and novel immunotherapeutic approaches.

Ovarian Cancer Diagnostic Key Market Trends

  • The increased understanding of certain cancer biomarkers is gaining a commercial opportunity for treating cancer patients through developed detection technology and equipment. Technological advances in the field of biotechnology have enabled the identification of potential cancer biomarkers, and some of these biomarkers have been commercialised. As a result, the development of new diagnostic biomarkers is opening up lucrative opportunities for the growth of the ovarian cancer diagnostics market.

Ovarian Cancer Diagnostic Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.

According to our ovarian cancer diagnostics market analysis, top market players' new product developments and product launch strategies The easy availability of diagnostic medical devices in developing regions, rising geriatric women population, increased emphasis on early diagnosis and treatment, increased funding for research activities to launch non-invasive treatment therapies, and increased studies on novel approaches in ovarian cancer treatment are all expected to drive demand for the ovarian cancer diagnostics market.

Report Metric Details
Market size value in 2023 USD 1.57 billion
Market size value in 2031 USD 9.67 billion
Growth Rate 23.7%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Type
    • Epithelial tumours, germ cell tumours, stromal tumours
  • End user
    • Hospital Laboratories, diagnostic centres, Research Institutes, others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Abbott Laboratories
  • Roche
  • Quest Diagnostics
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Becton, Dickinson and Company (BD)
  • bioMérieux SA
  • Hologic, Inc.
  • Illumina, Inc.
  • Myriad Genetics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Genomic Health, Inc.
  • Agilent Technologies
  • AstraZeneca
  • Bio-Rad Laboratories, Inc.
  • GE Healthcare
  • Merck KGaA
  • NanoString Technologies
  • Oncocyte Corporation
  • PerkinElmer Inc.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

Historical Year 2019

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Ovarian Cancer Diagnostic Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Ovarian Cancer Diagnostic Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Ovarian Cancer Diagnostic Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Ovarian Cancer Diagnostic Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Ovarian Cancer Diagnostic Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Ovarian Cancer Diagnostic Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Ovarian Cancer Diagnostic Market size was valued at USD 1.57 billion in 2019 and is poised to grow from USD 1.77 billion in 2023 to USD 9.67 billion by 2031, growing at a CAGR of 23.7% in the forecast period (2024-2031).

ovarian cancer diagnostics market is highly competitive and fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, acquisitions, co-development deals, product launches & development, collaborations and partnerships are adopted by these players to thrive in the competitive market. The most recent advancements in ovarian cancer diagnostics are desperately needed in the industry to detect cancer in its early stages and treat it without causing significant damage to the affected person's internal organs. Top ovarian cancer diagnosis instrument manufacturers are investing in research and development of devices and instruments that will aid in the diagnosis and treatment of ovarian cancer more effectively and efficiently. 'Abbott Laboratories', 'Roche', 'Quest Diagnostics', 'Siemens Healthineers', 'Thermo Fisher Scientific', 'Becton, Dickinson and Company (BD)', 'bioMérieux SA', 'Hologic, Inc.', 'Illumina, Inc.', 'Myriad Genetics, Inc.', 'F. Hoffmann-La Roche Ltd.', 'Genomic Health, Inc.', 'Agilent Technologies', 'AstraZeneca', 'Bio-Rad Laboratories, Inc.', 'GE Healthcare', 'Merck KGaA', 'NanoString Technologies', 'Oncocyte Corporation', 'PerkinElmer Inc.'

Increase in the number of elderly women is driving the ovarian cancer diagnostics market. The growing elderly female population leads to the increase in the chances of infected ovarian cancer. This increase in population has the potential to drive the ovarian cancer diagnostics market. As a result, governments launch initiatives to expand health care and treatment.

The increased understanding of certain cancer biomarkers is gaining a commercial opportunity for treating cancer patients through developed detection technology and equipment. Technological advances in the field of biotechnology have enabled the identification of potential cancer biomarkers, and some of these biomarkers have been commercialised. As a result, the development of new diagnostic biomarkers is opening up lucrative opportunities for the growth of the ovarian cancer diagnostics market.

North America accounted for more market value growth this is because of strong commercial performances of gynecologic diagnostics in the United States. Other factors contributing to the growth of the market in this region include favourable government initiatives, increase in healthcare expenditure, and presence of key manufacturers.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Ovarian Cancer Diagnostic Market

Product ID: SQMIG35F2014

$5,300
BUY NOW GET FREE SAMPLE